CVRS News and Press, Corindus Vascular Robotics Inc. (DE) From 05/17/19

Company to feature latest milestones and technology advancements in vascular robotics at SCAI 2019 Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, will sponsor ...

Corindus Vascular Robotics ( CVRS +31.9% ) is up on more than a 4x surge in volume on the heels of its Q1 report and update on CorPath sales. More news on: Corindus Vascular Robotics, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...

Corindus Vascular Robotics ( CVRS +13.8% ) reports Q1 revenue growth of 104% Y/Y to $3.04M. More news on: Corindus Vascular Robotics, Inc., Stocks on the move Read more ...

Chanticleer Holdings (NASDAQ: BURG ) +64%  on partnering with Beyond Meat. More news on: Chanticleer Holdings, Inc., Gevo, Inc., Yield10 Bioscience, Inc., Stocks on the move, Read more ...

Corindus Vascular Robotics, Inc. (CVRS) Q1 2019 Earnings Conference Call May 07, 2019, 04:30 PM ET Company Participants Judy DiClemente - IR Mark Toland - CEO David Long - CFO Conference Call Participants Drew Ranieri - Stifel Jeffrey Cohen - Ladenburg Thalmann Present...

Gainers: SGMS   +8.7% . CVRS   +8.6% . QRVO   +8.5% . AVLR   +8.3% . MTCH   +6.7% . More news on: Scientific Games Corporation, Corindus Vascular Robotics, Inc., Qorvo, Inc., Stocks on the move, Read more ...

Corindus Vascular Robotics (NYSEMKT: CVRS ): Q1 GAAP EPS of -$0.05 misses by $0.01 . More news on: Corindus Vascular Robotics, Inc., Earnings news and commentary, Consumer stocks news, Read more ...

Eleven purchase orders for CorPath GRX Systems as adoption grows Corindus Vascular Robotics , Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2019. Recent Financial Highlights ...

Chesapeake Regional Medical Center installs CorPath ® GRX Vascular Robotic Systems in all catheterization labs Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular r...

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release first quarter 2019 financial and business results on Tuesday, May 7, 2019 after the close of the U.S. financial markets. Mark Toland, President...